Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
136-150 of 232
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiersBridging the Gap: New Consensus Recommendations for Adult DMD Care
Rosaline Quinlivan
Ryan Quigley
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
Rosaline Quinlivan
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Richard Nowak, MD, MS
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Richard Nowak, MD, MS
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiersImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Andrew J. Solomon, MD
- advertisement
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
On the Frontlines of CIDPAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Karissa Gable, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple SclerosisEnhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Mark Gudesblatt, MD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiersHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Kelly Sloane, MD
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiersInflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Prajwal Ciryam, MD, PhD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiersGut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple SclerosisManaging MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP
Kimberly DiMauro, DO
Carol Swetlik, MD
- advertisement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple SclerosisAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Charles Turck, PharmD, BCPS, BCCCP
Yinan Zhang, MD
Sarah A. Morrow, MD, MS, FRCPC, FAAN
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
Marisa McGinley, DO
Understanding Schizophrenia: Early Intervention and Prevention Strategies
On the Frontlines of SchizophreniaUnderstanding Schizophrenia: Early Intervention and Prevention Strategies
Joseph F. Goldberg, MD
